A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of CR8020 in Japanese Healthy Participants

NCT02015533 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped The study was terminated due to an unexpected preliminary result obtained from the study with CR8020.

Conditions

Interventions

Sponsor

Janssen Pharmaceutical K.K.